News

By Priscila Mayumi Kashiwabara

August 15, 2022

Protecting Plant Varieties in Brazil for FloraCulture Magazine

Our partner and head of Life Sciences, Priscila Kashiwabara discusses plant variety protection in Brazil and its recent developments regarding legal framework for Plant Protecting Plant Varieties in Brazil for FloraCulture Magazine

Ler notícia

March 28, 2022

Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events

On March 17, 2022, the BPTO released the INPI/CPAPD technical note No. 01/2022, which provides guidance on the patentability of inventions involving Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events

Ler notícia

February 14, 2022

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that Life sciences patent eligibility in Latin America: a guide

Ler notícia

February 8, 2022

News on apostille of letters-patent retroactively affected by the Direct Plea of Unconstitutionality 5,529

On February 8th, 2022, the Brazilian Patent Office reported the decision to apostille letters-patent when the patent protects subject-matter going beyond the News on apostille of letters-patent retroactively affected by the Direct Plea of Unconstitutionality 5,529

Ler notícia

July 5, 2021

Personalised medicine in Brazil: IP and regulatory challenges

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first Personalised medicine in Brazil: IP and regulatory challenges

Ler notícia

March 30, 2021

Brazilian PTO extends the Patent Backlog Fighting Project

Continuing with the goal of reducing the number of patent applications pending decision, the Brazilian PTO (“BPTO”) published the Ordinance/INPI/PR N° 21, Brazilian PTO extends the Patent Backlog Fighting Project

Ler notícia

December 3, 2020

UN removes Cannabis from List of Narcotic Substances

On December 2, 2020, through its Commission on Narcotics, the United Nations approved a recommendation issued by WHO – World Health Organization UN removes Cannabis from List of Narcotic Substances

Ler notícia

December 2, 2020

Revised Guidelines for the Examination of Patent Applications in the Biotechnology field in force

The Revised Guidelines for the Examination of Patent Applications in the Biotechnology Field (Normative Instruction INPI/PR n° 118/2020) finally entered into force Revised Guidelines for the Examination of Patent Applications in the Biotechnology field in force

Ler notícia

November 26, 2020

ANVISA published manuals related to prior consent of patent applications

The Brazilian FDA (ANVISA) published on November 19, 2020, four manuals regarding the analysis of prior consent of patent applications related to ANVISA published manuals related to prior consent of patent applications

Ler notícia

May 29, 2020

Biologics and biosimilars in Brazil – the strategic questions

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil Biologics and biosimilars in Brazil – the strategic questions

Ler notícia

July 10, 2019

BPTO publishes resolutions that will initiate the “Patent Backlog-fighting Project”

As part of the “Patent Backlog-fighting Project”, the Brazilian Patent and Trademark Office (BPTO) published Resolutions INPI Nos. 240/19 and 241/19 on BPTO publishes resolutions that will initiate the “Patent Backlog-fighting Project”

Ler notícia